Best Researcher Award
Sajid Khan Sadozai
Erciyes University Kayseri, Turkey
| Research Profile |
| Affiliation |
Erciyes University Kayseri |
| Country |
Turkey |
| Scopus ID |
55213889200 |
| Documents |
25 |
| Citations |
320 |
| h-index |
8 |
| Subject Area |
Medicine and Health Sciences |
| Event |
Computer Scientists Awards |
| ORCID |
0000-0003-4958-5620 |
Sajid Khan Sadozai is a researcher affiliated with Erciyes University Kayseri, Turkey, whose scholarly activities focus primarily on medicine, pharmaceutical sciences, drug delivery technologies, electrochemical sensing, antimicrobial stewardship, and clinical pharmacy. His publication portfolio demonstrates interdisciplinary collaboration spanning pharmaceutical formulation, analytical chemistry, healthcare optimization, and biomedical applications. With a Scopus profile comprising 25 indexed documents, 320 citations, and an h-index of 8, his research reflects sustained scientific productivity and measurable academic influence.[1]
Abstract
This article summarizes the academic profile of Sajid Khan Sadozai and evaluates his suitability for recognition through the Best Researcher Award. His research integrates pharmaceutical sciences, analytical chemistry, nanotechnology, drug delivery systems, antimicrobial stewardship, and healthcare quality improvement. Recent publications demonstrate contributions to electrochemical detection techniques, nanoparticle-based drug delivery, pharmaceutical economics, and clinical audit methodologies. These multidisciplinary activities indicate a consistent commitment to improving therapeutic outcomes and advancing biomedical research through evidence-based investigation.[2]
Keywords
Medicine, Pharmaceutical Sciences, Drug Delivery, Electrochemical Sensors, Nanotechnology, Clinical Pharmacy, Antimicrobial Stewardship, Pharmacoeconomics, Biomedical Research, Best Researcher Award.
Introduction
Modern healthcare research increasingly relies on interdisciplinary approaches that combine pharmaceutical innovation with analytical technologies and clinical practice. Sajid Khan Sadozai has contributed to this evolving landscape through investigations addressing medicine formulation, therapeutic monitoring, pharmaceutical management, and diagnostic methodologies. His publications illustrate a balanced combination of laboratory experimentation and applied healthcare research while supporting improvements in patient care and pharmaceutical practice.[3]
Research Profile
- Scopus-indexed publication portfolio with 25 research documents.
- More than 320 scholarly citations and h-index of 8.
- Research spanning pharmaceutical formulation, electrochemical sensing, clinical pharmacy, and biomedical nanotechnology.
- Active collaboration across medicine and health sciences.
Research Contributions
His investigations include electrochemical detection of pharmaceutical compounds using UiO-66 modified electrodes, advanced nanoformulations for localized drug delivery, amphotericin B liposomal systems targeting macrophages, cost-effectiveness analyses of antihypertensive therapy, and antimicrobial stewardship initiatives in tertiary healthcare institutions. Collectively, these studies demonstrate practical relevance by addressing pharmaceutical efficacy, diagnostic sensitivity, and healthcare quality improvement while contributing to scientific literature.[4]
Publications
- Enhanced Electrochemical Detection of Risperidone Using UiO-66 Modified Screen-Printed Carbon Electrode (2026).
- Performance comparison of throat spray nanoformulations containing encapsulated lidocaine (2025).
- Cost-effectiveness analysis of antihypertensive medications (2025).
- Audit of antibiotic use and antimicrobial stewardship (2025).
- Chondroitin sulfate modified liposome nanoparticles for amphotericin B delivery (2025).
Research Impact
The research impact of Sajid Khan Sadozai is reflected through citation performance, interdisciplinary collaborations, and publication in peer-reviewed international journals. His work supports advances in pharmaceutical technology, analytical detection methods, and evidence-based healthcare management. The integration of laboratory innovation with clinical applications enhances the translational value of his research and contributes to improved therapeutic strategies.[5]
Award Suitability
Based on publication productivity, citation metrics, interdisciplinary scholarship, and contributions to medicine and pharmaceutical sciences, Sajid Khan Sadozai demonstrates characteristics commonly associated with academic excellence. His sustained research output, international visibility, and practical healthcare applications provide an evidence-based foundation for consideration within the Best Researcher Award category of the Computer Scientists Awards.[1]
Conclusion
Sajid Khan Sadozai has established a scholarly profile characterized by multidisciplinary research, peer-reviewed publications, and measurable scientific influence. His work bridges pharmaceutical innovation, biomedical engineering, and clinical healthcare while supporting evidence-based practice. Continued contributions in these areas are expected to strengthen research capacity and promote advancements within medicine and health sciences.
External Links
References
- Elsevier. (n.d.). Scopus author details: Sajid Khan Sadozai, Author ID 55213889200. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=55213889200
- Analytical Letters. (2026). Enhanced Electrochemical Detection of Risperidone Using UiO-66 Modified Screen-Printed Carbon Electrode.
https://doi.org/10.1080/00032719.2026.2680192
- Journal of Drug Delivery Science and Technology. (2025). Investigation and comparison of throat spray nanoformulations.
https://doi.org/10.1016/j.jddst.2025.107619
- Drug Development and Industrial Pharmacy. (2025). Ameliorated delivery of amphotericin B to macrophages using chondroitin sulfate surface-modified liposome nanoparticles.
https://doi.org/10.1080/03639045.2024.2443007
- Currents in Pharmaceutical Research. (2025). Clinical pharmacy studies on antihypertensive therapy and antimicrobial stewardship.
https://doi.org/10.32350/cpr.31.05